Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +1.00% | +13.85% | -26.81% |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
Apr. 26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.81% | 195M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.44% | 23.47B | |
-13.89% | 21.9B | |
-6.08% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Bluebird Bio : 'Encouraged' by Latest Results From Study of Cerebral Adrenoleukodystrophy